Neovacs S.A. (ALNEV.PA)

EUR 1.11

(-11.15%)

Total Assets Summary of Neovacs S.A.

  • Neovacs S.A.'s latest annual total assets in 2023 was 47.53 Million EUR , down -3.55% from previous year.
  • Neovacs S.A.'s latest quarterly total assets in 2024 Q2 was 38.89 Million EUR , down 0.0% from previous quarter.
  • Neovacs S.A. reported annual total assets of 49.28 Million EUR in 2022, up 1.51% from previous year.
  • Neovacs S.A. reported annual total assets of 48.55 Million EUR in 2021, up 260.03% from previous year.
  • Neovacs S.A. reported quarterly total assets of 47.53 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Neovacs S.A. reported quarterly total assets of 47.53 Million EUR for 2023 FY, down -3.55% from previous quarter.

Annual Total Assets Chart of Neovacs S.A. (2023 - 2009)

Historical Annual Total Assets of Neovacs S.A. (2023 - 2009)

Year Total Assets Total Assets Growth
2023 47.53 Million EUR -3.55%
2022 49.28 Million EUR 1.51%
2021 48.55 Million EUR 260.03%
2020 13.48 Million EUR 78.92%
2019 7.53 Million EUR 4.12%
2018 7.23 Million EUR -37.97%
2017 11.66 Million EUR 17.93%
2016 9.89 Million EUR -14.35%
2015 11.55 Million EUR 23.47%
2014 9.35 Million EUR 18.36%
2013 7.9 Million EUR 22.18%
2012 6.47 Million EUR -51.14%
2011 13.24 Million EUR 21.0%
2010 10.94 Million EUR 138.87%
2009 4.58 Million EUR 0.0%

Peer Total Assets Comparison of Neovacs S.A.

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR -223.138%
ABIVAX Société Anonyme 327.06 Million EUR 85.466%
Adocia SA 24.95 Million EUR -90.47%
Aelis Farma SA 26.28 Million EUR -80.867%
Biophytis S.A. 11.93 Million EUR -298.237%
Advicenne S.A. 12.4 Million EUR -283.119%
genOway Société anonyme 31.84 Million EUR -49.278%
IntegraGen SA 8 Million EUR -494.144%
Medesis Pharma S.A. 1.92 Million EUR -2367.566%
NFL Biosciences SA 3.97 Million EUR -1097.13%
Plant Advanced Technologies SA 14.91 Million EUR -218.741%
Quantum Genomics Société Anonyme 3.74 Million EUR -1168.655%
Sensorion SA 46.49 Million EUR -2.236%
Theranexus Société Anonyme 7.23 Million EUR -556.747%
TME Pharma N.V. 2.49 Million EUR -1808.213%
Valbiotis SA 33.24 Million EUR -42.967%
TheraVet SA 7.53 Million EUR -530.905%
Valerio Therapeutics Société anonyme 35.27 Million EUR -34.755%
argenx SE 4.11 Billion EUR 98.844%
BioSenic S.A. 9.55 Million EUR -397.265%
Celyad Oncology SA 16.28 Million EUR -191.94%
DBV Technologies S.A. 165.65 Million USD 71.305%
Galapagos NV 4.35 Billion EUR 98.909%
Genfit S.A. 173.87 Million EUR 72.662%
GeNeuro SA 6.31 Million EUR -652.96%
Hyloris Pharmaceuticals SA 47.68 Million EUR 0.309%
Innate Pharma S.A. 184.19 Million EUR 74.194%
Inventiva S.A. 69.13 Million EUR 31.249%
MaaT Pharma SA 42.93 Million EUR -10.721%
MedinCell S.A. 36.94 Million EUR -28.65%
Nanobiotix S.A. 93.89 Million EUR 49.377%
Onward Medical N.V. 43.62 Million EUR -8.95%
Oryzon Genomics S.A. 106.9 Million EUR 55.535%
OSE Immunotherapeutics SA 81.9 Million EUR 41.961%
Oxurion NV 6.55 Million EUR -625.704%
Pharming Group N.V. 426.33 Million EUR 88.851%
Poxel S.A. 4.82 Million EUR -885.561%
GenSight Biologics S.A. 9.08 Million EUR -423.094%
Transgene SA 45.21 Million EUR -5.123%
Financière de Tubize SA 1.92 Billion EUR 97.525%
UCB SA 15.53 Billion EUR 99.694%
Valneva SE 469.39 Million EUR 89.873%
Vivoryon Therapeutics N.V. 30.82 Million EUR -54.185%